pharma.bayer.comHome | Pharmaceuticals

Sorry, you need to enable JavaScript to visit this website. ////// Science for a better life Global Media/Press Report a Side Effect Contact English Deutsch Pharmaceuticals Living with a Disease Living with a Disease Quality of life is a mutual responsibility for all of us. Overview Cancer TRK Fusion Cancer Gastrointestinal Stromal Tumor Liver Cancer Prostate Cancer Kidney Cancer Breast Cancer Thyroid Cancer Virtual Press Room Cardiovascular & Kidney Diseases Thrombosis Heart Attack Chronic Kidney Disease Heart Failure High Blood Pressure Stroke & Atrial Fibrillation Diagnosing Heart Disease Eye Conditions Diabetic macular edema Age-related Macular Degeneration Hemophilia Women’s Healthcare Contraception Heavy Menstrual Bleeding Menopausal Complaints Endometriosis Uterine Fibroids Acne Therapy Other Diseases Pulmonary Hypertension Innovation Innovation For over 120 years, Bayer has been researching and developing innovative medications and new therapeutic approaches that help make a difference to people’s lives. Overview Technologies RNA interference High-throughput screening Digitalization in drug discovery PROTACs Diagnostic imaging Trends AAV Therapeutics Cell Therapy - Stem Cells Pharmacogenetics Targeted-thorium Conjugates Precision medicine Biomarkers AI in Pharma Development Pipeline Pipeline Insights Clinical Trials Ethics in Clinical Trials FAQ Transparenz-Richtlinie Zugang zu Medikamenten Partnering Partnering Bayer is a reliable and flexible partner who can help you take your work to the next stage and make the most out of its potential. Overview Why we Partner Areas of Interest Partnering With us Forms of Collaboration Chemical Probes for Open Access Blog Partnering Insights Where to Meet us Who we are Who we are We are committed to the principles of sustainable development. With our products we aim to improve people’s quality of life. Overview Championing Health for All Leadership Perspective Strengthening Healthcare Access Empowering Women, Globally Fighting Neglected Tropical Diseases Moving Non-Communicable Disease Care Forward Ensuring a Sustainable Product Supply Our Engagement Patient organization Patient Engagement #WeWontRest Transforming Healthcare Hub Healthy Aging Hub Global Health Policy Newsletter Search English German Results per page 10 Results per page 20 Results per page 30 Results per page 50 Results per page 100 Results per page Mobile Navigation Welcome to Bayer Pharmaceuticals You Need Commitment, Focus And Passion to Fight Diseases. Search English German Results per page 10 Results per page 20 Results per page 30 Results per page 50 Results per page 100 Results per page I am a Patient I am a Professional I am a Partner Latest News Innovation Development Pipeline Read More Twitter Bayer Pharma April 27, 2021 Explanations to the Supervisory Board Report - Prof. Dr. Norbert Winkeljohann READ MORE April 27, 2021 Address by Werner Baumann READ MORE April 10, 2021 Not intended for U.S. and UK Media – Plenary Session at AACR Annual Meeting 2021: Combination of copanlisib and rituximab significantly increases progression-free survival in patients with relapsed indolent non-Hodgkin’s Lymphoma READ MORE April 06, 2021 Not intended for U.S. and UK Media Bayer to present new clinical data in indolent non-Hodgkin’s Lymphoma and additional research on its oncology portfolio at AACR Annual Meeting 2021 READ MORE March 23, 2021 Not intended for U.S. and UK Media Bayer receives approval for Vitrakvi™ in Japan READ MORE NEWS OVERVIEW Update on Covid-19 Our Commitment During the Coronavirus Pandemic Explore Your Topic Current Topics - Any - Access to drugs in development advance Latin America’s economies AI in Drug Discovery AI in Pharma Areas of interest Biomarkers Cancer cancer care for ASEAN patients Cancer Diagnosis cancer genomics cancer research cardiovascular disease China’s healthcare journey Clinical Trials Conditions of Use Data Privacy Development pipeline Digitalization in drug discovery Drug development Ethics in clinical trails ETHICS IN R&D Expert Patient Eye Conditions Family Plannings FAQ FDA Forms of collaboration Frequently asked questions gastrointestinal stromal tumor General Innovation & Research articles Genomic Cancer Genomic testing gist Global health policy Health policy insights Healthy Aging heart and blood conditions Heart And Blood Disorders heart attack hemophilia Immunotherapy Imprint Innovation innovative pharma industry Latin America’s economies liver cancer Living with a Disease Multiple Scierosis Neglected Diseases oncology treatment ONKOLOGIE Our engagement Our Engagements Our partners Partnering Partnering with us Patient engagement patient organizations Patient recruitment Precision Medicine project in Ghana prostate cancer protect patients renal cell carcinoma Research & Development Areas Silver Economy Starving cancer cells Stem cell therapy stroke Targeted-thorium conjugates Technologies Technology-driven disease thrombosis thyroid cancer Trends TRK fusion United to improve patients’ lives Who we are Women Affected Diseases Worldwide standards Current Topics All Who we are Our engagement ETHICS IN R&D Innovation Transforming Healthcare. For People. The Long Hunt For The Next Beakthrough Read More A Deadly Threat Chagas Disease Read More Healthy Aging How digital health solutions can help people age better Read More Healthy Aging How can I Stay Healthy? Read more Innovation Pipeline Insights Stories Read more Current Topics - Any - Access to drugs in development advance Latin America’s economies AI in Drug Discovery AI in Pharma Areas of interest Biomarkers Cancer cancer care for ASEAN patients Cancer Diagnosis cancer genomics cancer research cardiovascular disease China’s healthcare journey Clinical Trials Conditions of Use Data Privacy Development pipeline Digitalization in drug discovery Drug development Ethics in clinical trails ETHICS IN R&D Expert Patient Eye Conditions Family Plannings FAQ FDA Forms of collaboration Frequently asked questions gastrointestinal stromal tumor General Innovation & Research articles Genomic Cancer Genomic testing gist Global health policy Health policy insights Healthy Aging heart and blood conditions Heart And Blood Disorders heart attack hemophilia Immunotherapy Imprint Innovation innovative pharma industry Latin America’s economies liver cancer Living with a Disease Multiple Scierosis Neglected Diseases oncology treatment ONKOLOGIE Our engagement Our Engagements Our partners Partnering Partnering with us Patient engagement patient organizations Patient recruitment Precision Medicine project in Ghana prostate cancer protect patients renal cell carcinoma Research & Development Areas Silver Economy Starving cancer cells Stem cell therapy stroke Targeted-thorium conjugates Technologies Technology-driven disease thrombosis thyroid cancer Trends TRK fusion United to improve patients’ lives Who we are Women Affected Diseases Worldwide standards Real Life Stories: Anita Real Life Stories: Anita Read More Real Life Stories: Nsubuga Bruhan Nsubuga Bruhan; Imam and Local Council Official Read More Pipeline Insights Unleashing the Power of Alpha for HER2-expressing Tumors Read More Quick Links Innovation & Research Pharmacogenetics Ethics in clinical trials Precision medicine Show More Our Engagement 30 Years From Now Read More Global Health Policy Blog Current Topics - Any - Access to drugs in development advance Latin America’s economies AI in Drug Discovery AI in Pharma Areas of interest Biomarkers Cancer cancer care for ASEAN patients Cancer Diagnosis cancer genomics cancer research cardiovascular disease China’s healthcare journey Clinical Trials Conditions of Use Data Privacy Development pipeline Digitalization in drug discovery Drug development Ethics in clinical trails ETHICS IN R&D Expert Patient Eye Conditions Family Plannings FAQ FDA Forms of collaboration Frequently asked questions...